CenterBook Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
+81,005
New +$1.13M 0.06% 337
2025
Q3
Sell
-42,728
Closed -$642K 645
2025
Q2
$642K Buy
42,728
+23,163
+118% +$331K 0.04% 401
2025
Q1
$258K Buy
+19,565
New +$270K 0.02% 458

Other funds holding RDY

CenterBook Partners's RDY Position: Q1 2026 in Review

CenterBook Partners opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2026: 81,005 shares worth $1.12M. The stake represents 0.06% of the portfolio and ranks #337 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in RDY as recently as Q2 2025.

CenterBook Partners first reported a position in RDY in Q1 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • CenterBook Partners held 81,005 shares of Dr. Reddy's Laboratories worth $1.12M as of Q1 2026.
  • Dr. Reddy's Laboratories was a new CenterBook Partners position in Q1 2026.
  • Dr. Reddy's Laboratories made up 0.06% of CenterBook Partners's portfolio in Q1 2026, its #337 holding.
  • CenterBook Partners first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.